Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Diopsys, Inc. is a medical device company dedicated to delivering innovative and accessible electrophysiologic vision testing solutions. Their patented technology provides eye care professionals with objective, functional information about the vision system to aid in the early detection and management of vision disorders, including glaucoma, macular degeneration, diabetic retinopathy, and amblyopia. Diopsys® VEP and ERG tests are designed to be patient-friendly and integrate seamlessly into clinical workflows, empowering clinicians with critical data for enhanced patient care.
The headquarters serves as the central hub for research and development, manufacturing, sales, marketing, customer support, and corporate administration for Diopsys's global operations.
The facility likely includes specialized R&D labs for medical device innovation, light manufacturing/assembly areas for their diagnostic systems, and modern office spaces designed for collaboration.
As a medical technology company, the work culture at Diopsys likely emphasizes innovation, precision, collaboration between engineering, clinical, and commercial teams, and a strong focus on improving patient outcomes in eye care.
This location is significant as it centralizes the core operations of the company, enabling efficient product development, quality control, and strategic planning for its specialized ophthalmic diagnostic tools.
Diopsys supports eye care professionals globally through its advanced VEP and ERG vision testing systems. While headquartered in the USA, its products are utilized in ophthalmology and optometry clinics across North America, Europe, Asia, and other international markets via a network of direct sales and distribution partners. They provide global support including clinical training and technical assistance for their devices.
300 Pike Road, Suite 102
Pine Brook
NJ
USA
Address: Diopsys primarily operates from its New Jersey headquarters. Information on other distinct physical office locations is not widely publicized.
Sales, customer training, technical support, and market development are managed through field-based personnel and distribution partners in various regions globally.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Diopsys' leadership includes:
Diopsys has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major, widely announced executive new hires or exits at Diopsys in the last 12 months. The leadership team appears to be stable.
Discover the tools Diopsys uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Diopsys likely utilizes common corporate email formats. The most probable pattern is the first initial followed by the last name, or first name followed by the last name, at their company domain.
[first_initial][last]@diopsys.com (e.g., jdoe@diopsys.com) or [first].[last]@diopsys.com (e.g., jane.doe@diopsys.com)
Format
jfontanetta@diopsys.com
Example
80%
Success rate
Eyewire News • October 19, 2023
Diopsys announced the commercial availability of its new Chromatic Pupillometry (CP) software module for the Diopsys ARGOS ERG and VEP Vision Testing System. This addition enhances the ARGOS device's capabilities by providing objective data on pupillary responses to different light wavelengths, aiding in the assessment of retinal ganglion cell function, which is crucial for glaucoma management....more
Eyewire News • March 2, 2023
Diopsys showcased its Enfant Pediatric VEP Vision Testing System at the 2nd Annual Women’s Eye Health Summit. The Enfant system is designed for early detection of vision deficits in young children, including amblyopia, by providing objective visual acuity assessments....more
Ophthalmology Times • September 29, 2022
An article highlighting how Diopsys's electroretinography (ERG) and visual evoked potential (VEP) technologies assist clinicians in diagnosing and managing a variety of retinal diseases by providing objective, functional data about the patient's visual pathway....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Diopsys, are just a search away.